COALITION FOR EPIDEMIC PREPAREDNES… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

NICOLE LURIE

Phone

2028000220

Tax Period

2024-01-01 to 2024-12-31

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS US, founded in 2017, is a community nonprofit in the Community Improvement sector that reported $9.8M in total revenue in fiscal year 2024. Revenue surged 49% from the prior year, signaling strong growth momentum.

Mission

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS US ("CEPI US") WAS ORGANIZED FOR SEVERAL PURPOSES:(1) TO EDUCATE THE AMERICAN PUBLIC ABOUT THE IMPORTANCE OF DEVELOPING VACCINES TO COMBAT FUTURE GLOBAL EPIDEMICS (SEE SCHEDULE O)AND CEPI'S GOALS OF COORDINATING THE DEVELOPMENT OF SUCH VACCINES;(2) TO COORDINATE THE EFFORTS OF CEPI'S PARTNERS THAT ARE LOCATED IN THE US, INCLUDING PRIVATE FOUNDATIONS, INDUSTRY, TRADE ASSOCIATIONS, ACADEMIC AND RESEARCH INSTITUTIONS, AND OTHER NOT-FOR-PROFITS; AND,(3) TO ADVOCATE FOR SUPPORT, INCLUDING POTENTIAL FUNDING FOR CEPI US BY THE U.S. GOVERNMENT.

Program Service Accomplishments

Program 1

Expenses: $9,752,148

IN A WORLD CHARACTERIZED BY INCREASING POPULATION DENSITY, HUMAN MOBILITY, AND ECOLOGICAL CHANGE, EMERGING INFECTIOUS DISEASES POSE A REAL AND GROWING THREAT TO GLOBAL HEALTH SECURITY. EPIDEMIC...

IN A WORLD CHARACTERIZED BY INCREASING POPULATION DENSITY, HUMAN MOBILITY, AND ECOLOGICAL CHANGE, EMERGING INFECTIOUS DISEASES POSE A REAL AND GROWING THREAT TO GLOBAL HEALTH SECURITY. EPIDEMIC DISEASES AFFECT EVERYBODY, AND DO NOT RESPECT BORDERS. VACCINES ARE ONE OF THEMOST POWERFUL TOOLS IN THE FIGHT TO OUTSMART EPIDEMICS. CEPI US'S MISSION IS TO STIMULATE AND ACCELERATE THE DEVELOPMENT OF VACCINES AGAINST EMERGING INFECTIOUS DISEASES AND ENABLE EQUITABLE ACCESS TO THESE VACCINES FOR AFFECTED POPULATIONS DURING OUTBREAKS. CEPI IS AN INNOVATIVE GLOBAL COALITION OF PUBLIC, PRIVATE, PHILANTHROPIC, AND CIVIL SOCIETY ORGANIZATIONS, WITH WHOM WE WORK IN PARTNERSHIP. CLOSE COLLABORATION WITH GLOBAL PARTNERS WILL BE CRUCIAL TO THE SUCCESS OF CEPIS WORK TO DEVELOP VACCINES AGAINST EMERGING (SEE SCHEDULE O) INFECTIOUS DISEASES. THEREFORE, CEPI WILL SUPPORT COORDINATING ACTIVITIES TO IMPROVE OUR COLLECTIVE RESPONSE TO EPIDEMICS, STRENGTHENING CAPACITY IN COUNTRIES AT RISK, AND ADVANCING THE REGULATORY SCIENCE THAT GOVERNS PRODUCT DEVELOPMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $9,670,823

Program Service Revenue $0

Investment Income $135,565

Other Revenue $0

TOTAL REVENUE $9,806,388

Expense Breakdown

Grants Paid $0

Salaries & Benefits $8,899,813

Fundraising Expenses $0

Program Expenses $9,752,148

Other Expenses $906,575

TOTAL EXPENSES $9,806,388

Year-over-Year Comparison

	2024	2023	Change
Revenue	$9,806,388	$6,594,258	+0.5%
Expenses	$9,806,388	$6,594,258	+0.5%
Net Income	$0	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,424,950

Total Directors

$1,277,462

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD HATCHETT	DIRECTOR, CEO	2.00	Officer Director	$0	$0	$799,685
NICOLE LURIE	DIRECTOR, PRESIDENT	40.00	Officer Director	$307,456	$27,384	$334,840
MADS HOGHOLEN	DIRECTOR, TREASURER	1.00	Officer Director	$0	$0	$142,937
MONINA VIERNEZA	SECRETARY	1.00	Officer	$0	$0	$147,488
DANIELLE CRAIG	REGULATORY AFFAIRS LEAD AM	40.00	Highest	$262,434	$71,116	$333,550
CHRISTOPHER T DA COSTA	PROJECT LEADER, R&D	40.00	Highest	$271,877	$53,946	$325,823
CATHERINE HOATH	REGULATORY AFFAIRS STRATEGY LEAD	40.00	Highest	$260,893	$63,810	$324,703
REBECCA FARKAS	HEAD OF TECHNOLOGY	40.00	Highest	$252,581	$70,749	$323,330
ANDREW HEBBELER	DIRECTOR OF BIOSECURITY	40.00	Highest	$263,575	$48,179	$311,754

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$9,806,388	$9,806,388	$4,611,016	No data
2024	$9,806,388	$9,806,388	$4,611,016	No data
2023	$6,594,258	$6,594,258	$3,740,346	No data
2022	$5,017,756	$5,017,756	$1,022,711	No data
2021	$3,699,855	$3,699,855	$496,981	No data
2020	$2,226,840	$2,226,840	$277,469	No data
2019	$1,247,912	$1,247,912	$236,551	No data
2018	$1,037,419	$1,037,419	$211,391	No data

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS US